C

Context Therapeutics
D

CNTX

1.37000
USD
-0.04
(-2.84%)
مغلق
حجم التداول
12,023
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
122,894,746
الأخبار المقالات

العنوان: Context Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.